LGRRX
Price
$23.69
Change
+$0.64 (+2.78%)
Updated
Apr 24 closing price
Net Assets
13.9B
RGEBX
Price
$66.60
Change
+$1.66 (+2.56%)
Updated
Apr 24 closing price
Net Assets
267.42B
Ad is loading...

LGRRX vs RGEBX

Header iconLGRRX vs RGEBX Comparison
Open Charts LGRRX vs RGEBXBanner chart's image
Loomis Sayles Growth A
Price$23.69
Change+$0.64 (+2.78%)
VolumeN/A
Net Assets13.9B
American Funds Growth Fund of Amer R2E
Price$66.60
Change+$1.66 (+2.56%)
VolumeN/A
Net Assets267.42B
LGRRX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGRRX vs. RGEBX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGRRX is a StrongBuy and RGEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 267B vs. LGRRX (13.9B). LGRRX (0.00) and RGEBX (0.00) have matching dividends . LGRRX was incepted earlier than RGEBX: LGRRX (28 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than LGRRX (0.92). RGEBX has a lower initial minimum investment than LGRRX: RGEBX (250) vs LGRRX (2500). LGRRX annual gain was more profitable for investors over the last year : 3.60 vs. RGEBX (0.80). RGEBX (40.73) and LGRRX (38.77) have equivalent 5 years return.
LGRRXRGEBXLGRRX / RGEBX
Total Expense Ratio0.911.0983%
Annual Report Gross Expense Ratio0.921.0984%
Fund Existence28 years11 years-
Gain YTD-12.557-6.775185%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets13.9B267B5%
Annual Yield % from dividends0.000.00-
Returns for 1 year3.600.80448%
Returns for 3 years15.6012.57124%
Returns for 5 years38.7740.7395%
Returns for 10 years119.8347.09254%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ULBI4.580.14
+3.15%
Ultralife Corp
FOX45.740.69
+1.53%
Fox Corp
REPX25.920.37
+1.45%
Riley Exploration Permian
AIMD0.55N/A
N/A
Ainos
PTGX44.85-1.31
-2.84%
Protagonist Therapeutics